Title  | Date  | Price |
|---|
Emerging Opportunities in Cancer Nanomedicine
| Aug 2006 |
£995 |
Global Diabetes Market; The
Therapeutics, Diagnostics and Complications
| Aug 2006 |
£1,500 |
Medicare Disease Management
Tactics to Improve Health, Education and Independence in an Aging Population
| Jul 2006 |
£76 |
Therapeutic Drug Market for Acne
Sector Snapshot
| May 2006 |
£310 |
Maternity Disease Management
Raising Expectations and Improving Outcomes
| May 2006 |
£76 |
Global Market for Adjunctive Therapies in Cancer, The
2nd Edition
| Apr 2006 |
£2,105 |
Chemotherapy Market Insights, 2006-2016
A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
| Apr 2006 |
£1,900 |
HIV: A Strategic Analysis of Therapeutic and Testing Markets
| Mar 2006 |
£2,105 |
Urinary Incontinence Markets
| Jan 2006 |
£310 |
World Market for Sexual Disorders, 2005-2012, The
Traversing New Frontiers in Sexual Chemistry
| Jan 2006 |
£795 |
Therapeutics for Inflammatory Diseases: Current Challenges and Future Market
| Jan 2006 |
£2,915 |
Global Market for Sleep-Wake Disorders, 2005-2012, The
Trends, Opportunities, and Insights in a High-Value CNS Therapy Area
| Dec 2005 |
£795 |
Modifying Patients' Behaviors to Optimize Disease Management Outcomes
| Dec 2005 |
£88 |
World Market for Addiction Disorders 2005-2012, The
New Horizons in High-Profile Dependency Markets
| Dec 2005 |
£1,100 |
Psychopharmacotherapy Market Insights
Obstacles & Opportunities in Mood Disorders & Cognitive Impairment, 2005-2012
| Nov 2005 |
£795 |
Depression Disease Management
Healthcare's New Frontier
| Aug 2005 |
£82 |
Pain Therapeutics 2005
Market Dynamics and Outlook
| May 2005 |
£1,200 |
Emotional and Behavioral Disorders in Children and Adolescents
| May 2005 |
£2,730 |
Disease Management & Obesity
Healthcare Impacts and Initiatives
| Dec 2004 |
£58 |
Cancer Vaccines
Measuring Market Potential
| Oct 2004 |
£900 |
Immunomodulators in Cancer Therapy
Emerging Products and Markets
| Aug 2004 |
£2,105 |
Analytical Tool: Competitive Outlook on HCV
| Jul 2004 |
£1,370 |
Inhaled Insulin
A Market Briefing
| Jul 2004 |
£540 |
Competitive Outlook on HCV
What to Know & Expect in R&D and Business Development
| Jun 2004 |
£915 |
HCV R&D and Business Development Database
| Jun 2004 |
£455 |
R&D Pipeline News - Technology Edition: 1-Year Subscription
Periodical
| Jan 1970 | |
R&D Pipeline News - Technology Edition: 1-Month Subscription
Periodical
| Jan 1970 | |
R&D Pipeline News - Therapeutic Area Edition: 1-Year Subscription
Periodical
| Jan 1970 | |
R&D Pipeline News - Therapeutic Area Edition: 1-Month Subscription
Periodical
| Jan 1970 | |
Pipeline and Commercial Insight: Hepatitis C
High unmet need drives rapid innovation
| Jan 1970 |
£8,070 |
Stakeholder Opinions: Narcolepsy
Entry-point to a lucrative fatigue-associated market
| Jan 1970 |
£2,315 |
Forecast Insight: Depression
Generic induced brand erosion leads to market decline
| Jan 1970 |
£8,070 |
Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia
Growth opportunities in fragmented markets
| Jan 1970 |
£2,285 |
first
previous
